LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

SHE:002644 Revenue

LanZhou Foci Pharmaceutical had revenue of 209.90M CNY in the quarter ending September 30, 2026, with 7.81% growth. This brings the company's total for the last twelve months to 941.70M, up 5.13% year-over-year. In the year 2025, LanZhou Foci Pharmaceutical had annual revenue of 915.53M, down -6.60%. That makes LanZhou Foci Pharmaceutical the 20,089th largest company in the world by revenue and 3,693rd in China.

• Revenue (ttm): 941.70M
• Revenue Growth: +5.13%
• P/S Ratio: 4.04
• Revenue / Employee: 706.98K
• Employees: 1,332
• Market Cap: 3.75B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 912.36M 99.7%
• Food Industry 3.17M 0.3%

By Geography

Chart

• China 804.88M 87.9%
• Foreign 110.65M 12.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002644 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	915.53M	-64.69M	-6.60%
Dec 31, 2024	980.23M	-182.91M	-15.73%
Dec 31, 2023	1.16B	120.75M	11.58%
Jan 1, 2023	1.04B	224.75M	27.49%
Jan 1, 2022	817.64M	149.59M	22.39%

Data Source: S&P Global Market Intelligence Last updated: Oct 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error